AG0039CD

38304-91-5 | 6-amino-2-imino-4-(piperidin-1-yl)-1,2-dihydropyrimidin-1-ol

AG0039CD

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	38304-91-5
Catalog Number	AG0039CD(AGN-PC-0O9M08)
Chemical Name	6-amino-2-imino-4-(piperidin-1-yl)-1,2-dihydropyrimidin-1-ol
EC Number	253-874-2
IUPAC Name	3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine
InChI	InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6,11,15H,1-5,10H2
InChI Key	ZIMGGGWCDYVHOY-UHFFFAOYSA-N
MDL Number	MFCD16039334
Molecular Formula	C9H15N5O
Molecular Weight	209.2483
NSC Number	757106
SMILES	NC1=NC(N2CCCCC2)=CC(N)=[N+]1[O-]
UNII	5965120SH1
Synonyms	Loniten, Minoxidil, Regaine, Rogaine, U 10858, minoxidil, 38304-91-5, Rogaine, Loniten, Regaine, Minoximen, Theroxidil, Tricoxidil, Alopexil, Alostil, Lonolox, Minoxidilum, Normoxidil, Prexidil, Minodyl, Minossidile [Italian], 2,6-Diamino-4-(piperidin-1-yl)pyrimidine 1-oxide, Minoxidilum [INN-Latin], Apo-Gain, U-10858, 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide, 2,4-Pyrimidinediamine, 6-(1-piperidinyl)-, 3-oxide, Avacor and Mintop, 6-(piperidin-1-yl)pyrimidine-2,4-diamine 3-oxide, 2,4-Diamino-6-piperidinopyrimidine 3-oxide, 6-Amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidinopyrimidine, MFCD00063409, MLS000028566, C9H15N5O, CHEBI:6942, 6-(1-Piperidinyl)pyrimidine-2,4-diamine 3-oxide, 6-[1-Piperidinyl]pyrimidine-2,4-diamine 3 oxide, 3-hydroxy-2-imino-6-(1-piperidyl)pyrimidin-4-amine, 2,6-diamino-4-(piperidin-1-yl)pyrimidin-1-ium-1-olate, NCGC00015673-08, Minossidile, Pierminox, SMR000058963, CAS-38304-91-5, DSSTox_CID_20685, DSSTox_RID_79541, 6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide, DSSTox_GSID_40685, RiUP, 6-(1-piperidinyl)-2,4-pyrimidinediamine-3-oxide, 6-amino-2-imino-4-(piperidin-1-yl)pyrimidin-1(2H)-ol, Minoxigaine, Trocoxidil, Neoxidil, Gen-Minoxidil, Rogaine for Men, ROGAINE (FOR MEN), Rogaine for Women, 2,6-diamino-4-piperidylpyrimidin-1-ol, MINOXIDIL (FOR MEN), ROGAINE (FOR WOMEN), SMR000326812, Loniten (TN), Minoxidil [USAN:BAN:INN], Rogaine (TN), MINOXIDIL (FOR WOMEN), Men s Rogaine Foam, Riup (TN), SR-01000075331, SR-05000001479, 3-oxido-6-piperidin-1-ylpyrimidin-3-ium-2,4-diamine, U 10858, ROGAINE EXTRA STRENGTH (FOR MEN), Kopdil, 2,6-Diamino-4-piperidinopyrimidin-1-oxid, MINOXIDIL EXTRA STRENGTH (FOR MEN), Rogaine Extra Strength for Men, 6-Piperidino-2,4-diaminopyrimidine 3-oxide, HSDB 6538, 2,4-Diamino-6-piperidinopyrimidine 3-N-oxide, Minoxidil,(S), UNII-5965120SH1, Prestwick_521, EINECS 253-874-2, U-10,858, TM-160, 2,4-Diamino-6-piperidinilpirimidina-3-ossido [Italian], BRN 0886240, MINOXIDIL EXTRA STRENGTH FOR MEN, pyrimidin-1(2H)-ol, Spectrum_000969, Tocris-0583, regid855572, 2,3-Dihydro-3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine, Opera_ID_1150, Prestwick0_000020, Prestwick1_000020, Prestwick2_000020, Prestwick3_000020, Spectrum2_001053, Spectrum3_000509, Spectrum4_000063, Spectrum5_001299, Lopac-M-4145, M1389, 2,4-Diamino-6-piperidino-pyrimidine-3-oxide, CHEMBL802, M 4145, AC1L1HN1, Minoxidil (JAN/USP/INN), CBiol_001798, Lopac0_000786, Pyrimidine, 2,4-diamino-6-piperidino-, 3-oxide, SCHEMBL29698, BSPBio_000059, BSPBio_001385, BSPBio_002037, KBioGR_000105, KBioGR_000585, KBioSS_000105, KBioSS_001449, MLS000859953, MLS001077294, DivK1c_000160, SCHEMBL232565, SPECTRUM1500415, SPBio_001006, SPBio_001980, 3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine, BPBio1_000065, CHEMBL609587, GTPL4254, Minoxidil, >=99% (TLC), SGCUT00112, ZINC1735, Jsp006715, CHEMBL1372483, DTXSID9040685, BCBcMAP01_000193, BDBM81463, C9H15N5.H2O, CHEBI:92128, HMS500H22, KBio1_000160, KBio2_000105, KBio2_001449, KBio2_002673, KBio2_004017, KBio2_005241, KBio2_006585, KBio3_000209, KBio3_000210, KBio3_001537, BIM0127, NINDS_000160, ZFMITUMMTDLWHR-UHFFFAOYSA-N, ZIMGGGWCDYVHOY-UHFFFAOYSA-N, BCPP000162, Bio1_000084, Bio1_000573, Bio1_001062, Bio2_000105, Bio2_000585, HMS1361F07, HMS1568C21, HMS1791F07, HMS1920P03, HMS1989F07, HMS2089L08, HMS2091F20, HMS2095C21, HMS2233E04, HMS2235N21, HMS3259P21, HMS3262M14, HMS3266O06, HMS3371E15, HMS3372M19, HMS3402F07, HMS3675G16, HMS3712C21, Pharmakon1600-01500415, ACT04612, BCP01409, CAS_4201, HY-B0112, KS-00000X2A, NSC_4201, to_000070, ZINC6507066, Tox21_110193, Tox21_500786, 3853AH, CCG-40112, GP5950, NSC757106, s1383, SBB056986, STL453211, AKOS015920078, AKOS016339636, Tox21_110193_1, 6-amino-2-imino-4-(piperidin-1-yl), AC-5271, API0003399, BCP9000929, CCG-220020, CS-1867, DB00350, GS-3605, KS-5164, LP00786, NC00686, NSC-757106, IDI1_000160, IDI1_033855, SMP1_000192, NCGC00015673-01, NCGC00015673-02, NCGC00015673-03, NCGC00015673-04, NCGC00015673-05, NCGC00015673-06, NCGC00015673-07, NCGC00015673-09, NCGC00015673-10, NCGC00015673-11, NCGC00015673-13, NCGC00018278-01, NCGC00018278-02, NCGC00018278-03, NCGC00018278-04, NCGC00024666-01, NCGC00024666-02, NCGC00024666-03, NCGC00024666-04, NCGC00024666-05, NCGC00024666-06, NCGC00024666-07, NCGC00024666-08, NCGC00179672-01, NCGC00261471-01, AN-11161, BC201579, BR-49175, CPD000058963, H766, SAM002589949, SC-16492, ZB000401, SBI-0050764.P004, AB0013244, AB0093459, AB1009393, LS-135040, 2,6-Diamino-4-piperidinopyrimidine 1-Oxide, 5965120SH1, AB00513797, EU-0100786, FT-0620793, ST24027359, ST50993884, D00418, J10235, M-7481, AB00052047-08, AB00052047_09, AB00052047_10, AB00513797-02, 102666-EP2272841A1, 102666-EP2281816A1, 102666-EP2301936A1, 304M915, A824098, 2,4-diamino-6-(1-piperidinyl)-pyrimidine-3-oxide, Q-201408, SR-01000075331-1, SR-01000075331-3, SR-01000075331-5, SR-05000001479-1, SR-05000001479-2, 3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine, BRD-K06902185-001-05-2, BRD-K06902185-001-10-2, BRD-K14888893-001-02-3, Minoxidil, British Pharmacopoeia (BP) Reference Standard, Z1541638524, Minoxidil, European Pharmacopoeia (EP) Reference Standard, 2-azanylidene-3-oxidanyl-6-piperidin-1-yl-pyrimidin-4-amine, 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidino-pyrimidine, Minoxidil, United States Pharmacopeia (USP) Reference Standard, 6-amino-2-imino-4-(piperidin-1-yl)-1,2-dihydropyrimidin-1-ol, Minoxidil for system suitability, European Pharmacopoeia (EP) Reference Standard, 6-(1-Piperidinyl)-2,4-pyrimidinediamine 3-oxide; 6-(1-Piperidinyl)pyrimidine-2,4-diamine 3-oxide, piroxicam, Men's Rogaine, Mintop, Mixture Name, Women's Rogaine, Sodium docosanoate, Mens Rogaine Foam, Regaine (TN), Minoxidil Pfizer Brand, Minoxidil (USP/INN), PfizerBrand of Minoxidil, D0Y2CJ, Minoxidil [USAN:INN:BAN], CID4201, Minoxidil [USAN:USP:INN:BAN], C9-H15-N5-O, ACN-052220, CS-O-11696, 2,4-Diamino-6-piperidinilpirimidina-3-ossido, B1289, Minoxidil, 98%, vasodilator agent - 5G 5g, A10593, Rogaine, Regaine, Avacor and Mintop, Minoxidil, 5-25-12-00317 (Beilstein Handbook Reference), D008914, PDP, Pyrimidine, 6-amino-1,2-dihydro-1-hydroxy-2-imino-4-piperidino-, 4-Pyrimidinamine, 2,3-dihydro-3-hydroxy-2-imino-6-(1-piperidinyl)-, 16317-69-4, 36322-90-4, 5331-77-1, 74974-60-0,

Complexity	329
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	209.128g/mol
Formal Charge	0
Heavy Atom Count	15
Hydrogen Bond Acceptor Count	3
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	209.253g/mol
Monoisotopic Mass	209.128g/mol
Rotatable Bond Count	1
Topological Polar Surface Area	88.9A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	1.2

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H332-H335
Packing Group
Precautionary statements	P261-P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number